Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide LAR for prevention of rebleeding from gastrointestinal angiodysplasias
2005-005313-38Phase 2Terminated
- Sponsor
- Klinikum rechts der Isar
- Start
- Mar 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of octreotide in angiodysplasia and gastrointestinal bleeding (2 arms), sponsored by Klinikum rechts der Isar. Primary endpoint: Frequency of recurrent hemorrhage. Started Mar 2006; status: terminated.
02
Drugs
octreotide
03
Conditions
angiodysplasiagastrointestinal bleeding
Beyond the preview
Go deeper on 2005-005313-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005313-38.